Management of Diabetic Peripheral Neuropathy / 대한내과학회지
Korean Journal of Medicine
;
: 277-281, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-52504
ABSTRACT
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. The prevalence of neuropathic pain is estimated to occur in about 30-50% of all diabetic patients. Clinical symptoms vary depending on the nerves affected, and may include both positive and negative symptoms. Many patients with DPN experience pain or discomfort, anxiety, depression, and limitations in activity, which can significantly impact their physical, emotional, and social well-being. Early diagnosis is essential for the successful management of DPN. Routine management consists of glucose and risk factor control, and symptomatic relief, along with therapies designed to target the underlying disease pathology. Pharmacological treatment of DPN includes tricyclic compounds, serotonin noradrenalin reuptake inhibitors, the antioxidant alpha-lipoic acid, anticonvulsants, opiates, membrane stabilizers, topical capsaicin, and other drugs. Management of DPN must be tailored to each individual, and depends on a variety of factors, including disease severity and response to treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Ansiedad
/
Patología
/
Capsaicina
/
Serotonina
/
Prevalencia
/
Factores de Riesgo
/
Ácido Tióctico
/
Enfermedades del Sistema Nervioso Periférico
/
Diagnóstico Precoz
/
Depresión
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
/
Estudio de prevalencia
/
Factores de riesgo
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS